Banaag, Owen E.

HRN: 28-02-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
OXACILLIN 500MG (VIAL)
05/30/2026
06/06/2026
IV
160mg
Q6
Staphylococcal SKin Infection
Checking Initial Appropriateness 
05/30/2026
CEFTRIAXONE 1G (VIAL)
05/30/2026
06/06/2026
IV
310mg
Q12
PCAP
Checking Initial Appropriateness 
05/30/2026
MUPIROCIN 2%, 15G (TUBE)
05/30/2026
06/06/2026
TOPICAL
On Affected Areas
BID
Staphylococcal SKin Infection
Checking Initial Appropriateness 
05/30/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/30/2026
06/06/2026
TOPICAL
On Affected Areas
TID
Diaper Rash
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: